SAB Biotherapeutics, Inc. (SABSW) NASDAQ
0.02
+0.0016(+9.41%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.02
+0.0016(+9.41%)
Currency In USD
| Market Cap | 72.23M |
| Enterprise Value | 67.67M |
| P/E Ratio | -467.8 |
| PEG Ratio | 14.24 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.82 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 10.83 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0 |
| Return On Equity | -0 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -3.08M |
| EBITDA | 16.6M |
| Net Income | 13.27M |
| Diluted EPS | -0.79 |
| Total Cash | 107.39M |
| Total Cash/Share | 2.01 |
| Total Debt | 6.17M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 11.45 |
| Book Value Per Share | 4.24 |
| 52-Week Change | -44.48 |
| 52-Week High | 0.05 |
| 52-Week Low | 0.02 |
| Moving Average 50 Days | 0.03 |
| Moving Average 200 Days | 0.03 |
| Average Volume | 24,322.14 |
| Shares Outstanding | 9.56M |
| % Held by Institutions | 4.2 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |